Physician profile
Eric T Elliott
NPI 1174655740
$662.26
in general payments reported to CMS, 2019-2025
9 companies · $242 in 2025
The $242 reported for 2025 was more than what 86% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.94 · 2022: $104 · 2023: $105 · 2024: $177 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $124.47 | 2023-2024 | Puraply |
| Kerecis Limited | $118.89 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $104.38 | 2022 | |
| Innovation Technologies INC | $88.13 | 2024 | Irrisept |
| Orthalign INC | $81.76 | 2025 | Orthalign Plus |
| Urgo Medical North America, LLC | $69.96 | 2024 | Urgok2 |
| Aroa Biosurgery Incorporated | $32.94 | 2019 | |
| Boston Scientific Corporation | $23.07 | 2025 | General - Non-Vascular Intervention |
| Solventum Corporation | $18.66 | 2025 | 3m Cavilon, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.